Antimicrobial activity of tulathromycin and 14 other antimicrobials against virulent Rhodococcus equi in vitro

Veterinary Therapeutics

Volumn 11, Issue 2, 2010, Pages

  Carlson, Kelly L ^a   Kuskie, Kyle R ^b   Chaffin, M Keith ^a   Libal, Melissa C ^b   Giguére, Steeve ^c   Lawhon, Sara D ^b   Cohen, Noah D ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DISACCHARIDE; HETEROCYCLIC COMPOUND; TULATHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; MICROBIAL SENSITIVITY TEST; PATHOGENICITY; RHODOCOCCUS EQUI; VIRULENCE;

ANTI-BACTERIAL AGENTS; DISACCHARIDES; DRUG RESISTANCE, BACTERIAL; HETEROCYCLIC COMPOUNDS; MICROBIAL SENSITIVITY TESTS; RHODOCOCCUS EQUI; VIRULENCE;

EQUIDAE; RHODOCOCCUS EQUI;

EID: 77956520983     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hines M. Rhodococcus equi. In: Sellon D, Long M, eds. Equine Infectious Diseases. St. Louis: Saunders; 2007:281-295.
2. Sweeney CR, Sweeney RW, Divers TJ. Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy. Vet Micro 1987;14(3):329-336.
3. Giguère S, Lee E, Cohen ND, et al. Prevalence of Rhodococcus equi isolates resistant to macrolides or rifampin and outcome of infected foals. JAVMA 2010; 237:74-81.
4. Nowakowski M, Inskeep P, Risk J, et al. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Vet Ther 2004;5(1):60-74.
5. Benchaoui H, Nowakowski M, Sherington J, et al. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol Ther 2004; 27:203-210.
6. Scheuch E, Spieker J, Venner M, Siegmund W.Quantitative determination of the macrolide antibiotic tulathromycin in plasma and broncho-alveolar cells of foals using tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 850:464-470.
7. Venner M, Kerth R, Klug E. Evaluation of tulathromycin in the treatment of pulmonary abscesses in foals. Vet J 2007;174:418-421.
8. Halbert N, Reitzel R, Martens R, Cohen N. Evaluation of a multiplex polymerase chain reaction assay for simultaneous detection of Rhodococcus equi and the vapA gene. Am J Vet Res 2005;66(8):1380-1385.
9. Jones R, Gavan T, Barry A. Evaluation of the Sensititre microdilution antibiotic susceptibility system against recent clinical isolates: three-laboratory collaborative study. J Clin Microbiol 1980;11(4):426-429.
10. Jones R, Gavan T, Barry A. Evaluation of the Sensititre system for quantitative antimicrobial drug susceptibility testing: a collaborative study. Antimicrob Agents Chemother 1980;17(3):464-469.
11. Prescott JF. Rhodococcus equi: an animal and human pathogen. Clin Microbiol Rev 1991;4(1):20-34.
12. Womble A, Giguère S, Murthy Y, et al. Pulmonary disposition of tilmicosin in foals and in vitro activity against Rhodococcus equi and other common equine bacterial pathogens. J Vet Pharmacol Ther 2006;29(6):561-568.
13. Clinical and Laboratory Standards Institute. Performancestandards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard-third edition. CLSI Document M31-A3; 2008:76.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement. CLSI Document M100-S19; 2009.
15. Roberts MC. Resistance to macrolide, lincosamide, streptogramin, ketolide and oxazolidinone antibiotics. Mol Biotechnol 2004;28:47-62.
16. Leclercq R, Courvalin P. Resistance to macrolides andrelated antibiotics in Streptococcus pneumoniae. Antimicrob Agents Chemother 2002;46:2727-2734.
17. Jacks S, Giguère S, Nguyen A. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin and 20 other antimicrobials. Antimicrob Agents Chemother 2003;47(5):1742-1745.
18. Bowersock T, Salmon S, Portis E, et al. MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals. Antimicrob Agents Chemother 2000;44(5):1367-1369.
19. McNeil M, Brown J. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens. Eur J Epidemiol 1992;8(3):437-443.
20. Vivrette SL, Bostian A, Bermingham E, Papich MG. Quinolone-induced arthropathy in neonatal foals. Proc AAEP 2001;47:376-377.
21. Papich M, Davis J. Antimicrobial therapy. In: Sellon D, Long M, eds. Equine Infectious Diseases. St. Louis: Saunders; 2007:578-591.